Hans Christian Korting

Hans Christian Korting's AcademicInfluence.com Rankings

Philosophy

#6742

World Rank

#9834

Historical Rank

Logic

#3862

World Rank

#5084

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Hans Christian Korting Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Hans Christian Korting was a German dermatologist and medical researcher specializing in causes and treatment of infectious and non-infectious inflammatory skin diseases as well as non-melanoma skin cancer".

(See a Problem?)

Hans Christian Korting's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies (2011) (1081)
The pH of the Skin Surface and Its Impact on the Barrier Function (2006) (625)
Lipid nanoparticles for improved topical application of drugs for skin diseases. (2007) (561)
Hydrolytic enzymes as virulence factors of Candida albicans (2005) (486)
Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety (2006) (349)
Candida albicans Hyphal Formation and the Expression of the Efg1-Regulated Proteinases Sap4 to Sap6 Are Required for the Invasion of Parenchymal Organs (2002) (273)
Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. (2005) (236)
Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity (1998) (227)
Toll-like receptors as key mediators in innate antifungal immunity. (2004) (223)
Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. (2007) (217)
The Use of Reconstructed Human Epidermis for Skin Absorption Testing: Results of the Validation Study (2008) (199)
In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus (1988) (198)
Drug Targeting by Solid Lipid Nanoparticles for Dermal Use (2002) (193)
Chronic Dermatomycoses of the Foot as Risk Factors for Acute Bacterial Cellulitis of the Leg: A Case-Control Study (2004) (181)
The Secreted Aspartyl Proteinases Sap1 and Sap2 Cause Tissue Damage in an In Vitro Model of Vaginal Candidiasis Based on Reconstituted Human Vaginal Epithelium (2003) (178)
Hyaluronic Acid in the Treatment and Prevention of Skin Diseases: Molecular Biological, Pharmaceutical and Clinical Aspects (2004) (169)
Toll-like receptors and innate antifungal responses. (2004) (165)
Targeting virulence: a new paradigm for antifungals. (2009) (160)
Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence. (2002) (149)
Effects of the Human Immunodeficiency Virus (HIV) Proteinase Inhibitors Saquinavir and Indinavir on In Vitro Activities of Secreted Aspartyl Proteinases of Candida albicans Isolates from HIV-Infected Patients (1999) (142)
The role of vitamin E in normal and damaged skin (2004) (141)
Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake. (2004) (138)
Differences in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0. Results of a crossover trial in healthy volunteers. (1990) (130)
Ciclopirox Olamine Treatment Affects the Expression Pattern of Candida albicans Genes Encoding Virulence Factors, Iron Metabolism Proteins, and Drug Resistance Factors (2003) (129)
Cyproterone Acetate Loading to Lipid Nanoparticles for Topical Acne Treatment: Particle Characterisation and Skin Uptake (2007) (126)
Sunscreens – Which and What for? (2005) (124)
Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. (2004) (121)
Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin‐independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death (2002) (121)
The Phenion® Full-Thickness Skin Model for Percutaneous Absorption Testing (2009) (120)
Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. (2000) (118)
1α,25-Dihydroxyvitamin D3 Protects Human Keratinocytes from Apoptosis by the Formation of Sphingosine-1-Phosphate (2001) (116)
Reconstructed Human Epidermis for Skin Absorption Testing: Results of the German Prevalidation Study (2006) (116)
Human defensins (2005) (115)
Therapeutic progress with topical liposome drugs for skin disease (1996) (113)
Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients (1995) (111)
Chitin Modulates Innate Immune Responses of Keratinocytes (2011) (110)
Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes (1993) (109)
Efficacy of cream-based novel formulations of hyaluronic acid of different molecular weights in anti-wrinkle treatment. (2011) (108)
The effect of detergents on skin pH and its consequences. (1996) (108)
Carriers in the topical treatment of skin disease. (2010) (106)
[Normal pH value of human skin]. (1986) (106)
Reconstructed epidermis versus human and animal skin in skin absorption studies. (2005) (104)
Candida albicans-Secreted Aspartic Proteinases Modify the Epithelial Cytokine Response in an In Vitro Model of Vaginal Candidiasis (2005) (102)
Influence of repeated washings with soap and synthetic detergents on pH and resident flora of the skin of forehead and forearm. Results of a cross-over trial in health probationers. (1987) (97)
Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases. (1999) (93)
Topical Glucocorticoids with Improved Risk-Benefit Ratio (1996) (87)
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. (2005) (86)
Skin Penetration and Metabolism of Topical Glucocorticoids in Reconstructed Epidermis and in Excised Human Skin (1999) (84)
Topical glucocorticoids with improved benefit/risk ratio: do they exist? (1992) (81)
Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group (1995) (80)
Xerosis and callus formation as a key to the diabetic foot syndrome: Dermatologic view of the problem and its management (2006) (79)
Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium. (2003) (79)
Phospholipases of Candida albicans (2001) (78)
Cationic membrane‐active peptides – anticancer and antifungal activity as well as penetration into human skin (2014) (78)
MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants. (1994) (77)
[Topical skin therapy with glucocorticoids--therapeutic index]. (2004) (76)
Chlamydia trachomatis induces an inflammatory response in the male genital tract and is associated with altered semen quality. (1991) (75)
Liposomal tretinoin for uncomplicated acne vulgaris (1994) (74)
Direct detection of five common dermatophyte species in clinical samples using a rapid and sensitive 24‐h PCR–ELISA technique open to protocol transfer (2011) (74)
Modes of Action of the New Arylguanidine Abafungin beyond Interference with Ergosterol Biosynthesis and in vitro Activity against Medically Important Fungi (2008) (72)
The concept of the acid mantle of the skin: its relevance for the choice of skin cleansers. (1995) (71)
Folliculitis decalvans. Long-lasting response to combined therapy with fusidic acid and zinc. (1992) (71)
In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. (1999) (69)
Toxicity and Antimicrobial Activity of a Hydrocolloid Dressing Containing Silver Particles in an ex vivo Model of Cutaneous Infection (2003) (69)
Lactobacilli - bacteria-host interactions with special regard to the urogenital tract. (2005) (67)
Hallmarks of Atopic Skin Mimicked In Vitro by Means of a Skin Disease Model Based on FLG Knock-down (2011) (66)
Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin. (1992) (65)
Discrimination of the irritancy potential of surfactants in vitro by two cytotoxicity assays using normal human keratinocytes, HaCaT cells and 3T3 mouse fibroblasts: correlation with in vivo data from a soap chamber assay. (1994) (64)
Prednicarbate Biotransformation in Human Foreskin Keratinocytes and Fibroblasts (1997) (63)
Different Skin Thinning Potential of Equipotent Medium-Strength Glucocorticoids (2002) (63)
The Munich outbreak of cutaneous cowpox infection: transmission by infected pet rats. (2012) (62)
Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole (1993) (61)
Tetracycline Actions Relevant to Rosacea Treatment (2009) (58)
HIV protease inhibitors influence the prevalence of oral candidosis in HIV‐infected patients: a 2‐year study (1998) (57)
Current and future approaches to antimycotic treatment in the era of resistant fungi and immunocompromised hosts. (2001) (57)
Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in mice. (2002) (55)
Coal tar, pine tar and sulfonated shale oil preparations: comparative activity, efficacy and safety. (1996) (55)
Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo. (2001) (53)
Influence of the pH-value on the growth of Staphylococcus epidermidis, Staphylococcus aureus and Propionibacterium acnes in continuous culture. (1992) (53)
Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. (2005) (52)
Liposome preparations: a step forward in topical drug therapy for skin disease? A review. (1989) (52)
In vitro models for human skin disease. (2011) (50)
The KEX2 gene of Candida glabrata is required for cell surface integrity (2001) (49)
Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action (2005) (49)
Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis. (2002) (49)
Actinic Keratosis: The Key Event in the Evolution from Photoaged Skin to Squamous Cell Carcinoma (2004) (49)
Evidence for the efficacy and safety of topical herbal drugs in dermatology: Part I: Anti-inflammatory agents. (1994) (48)
Sphingosine-1-Phosphate Signaling and the Skin (2007) (48)
Cutaneous Inflammation and Proliferation in vitro: Differential Effects and Mode of Action of Topical Glucocorticoids (2000) (47)
Letters to Dermatology (1998) (46)
Nicotinamide – biologic actions of an emerging cosmetic ingredient (2005) (46)
A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatment. (1998) (45)
A peptide derived from the highly conserved protein GAPDH is involved in tissue protection by different antifungal strategies and epithelial immunomodulation (2012) (45)
Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate. (2013) (45)
Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema (2004) (44)
Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids (1993) (43)
Anti-inflammatory activity of hamamelis distillate applied topically to the skin (1993) (43)
The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes (2009) (42)
In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new. (1995) (41)
Fifty-kDa Hyaluronic Acid Upregulates Some Epidermal Genes without Changing TNF-α Expression in Reconstituted Epidermis (2011) (41)
Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice. (1989) (41)
Induction of nuclear factor- kappa B and c-Jun/activator protein-1 via toll-like receptor 2 in macrophages by antimycotic-treated Candida albicans. (2004) (41)
Management of Onychomycoses (1999) (41)
Identification of dermatophytes by Fourier transform infrared spectroscopy (FT‐IR) (1999) (40)
Molecular and phenotypic identification of the yeast pathogen Candida dubliniensis (2000) (39)
Deep Subcutaneous Application of Poly-L-Lactic Acid as a Filler for Facial Lipoatrophy in HIV-Infected Patients (2005) (39)
Improved differentiation of benign and malignant lymphadenopathy in patients with cutaneous melanoma by contrast-enhanced color Doppler sonography. (2002) (39)
Sonographic determination of cutaneous and subcutaneous fibrosis after accidental exposure to ionising radiation in the course of the Chernobyl nuclear power plant accident. (1997) (38)
The influence of the regular use of a soap or an acidic syndet bar on pre-acne (1995) (37)
The crystal structure of the secreted aspartic proteinase 3 from Candida albicans and its complex with pepstatin A (2007) (37)
Impact of Age and Body Site on Adult Female Skin Surface pH (2012) (36)
Allergic contact dermatitis to cocamidopropyl betaine in shampoo. (1992) (35)
Host defence against Candida albicans and the role of pattern-recognition receptors. (2012) (35)
1Alpha,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate. (2001) (35)
Assessment of cutaneous and ocular irritancy: a decade of research on alternatives to animal experimentation. (1995) (35)
One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group. (2001) (34)
Interaction of liposomes with human skin: the role of the stratum corneum (1996) (34)
Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans. (2003) (33)
The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role. (2002) (33)
Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound. (1992) (33)
Antimicrobial Susceptibility Testing of Dermatophytes – Comparison of the Agar Macrodilution and Broth Microdilution Tests (1997) (32)
Glycosylation of Candida albicans Cell Wall Proteins Is Critical for Induction of Innate Immune Responses and Apoptosis of Epithelial Cells (2012) (32)
Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk (1996) (31)
Penciclovir Cream – Improved Topical Treatment for Herpes simplex Infections (2004) (31)
Light and electron microscopic findings in a model of human cutaneous candidosis based on reconstructed human epidermis following the topical application of different econazole formulations. (1999) (31)
Comparative Therapeutic and Toxic Effects of Different Povidone Iodine (PVP-I) Formulations in a Model of Oral Candidosis Based on in vitro Reconstituted Epithelium (2001) (30)
Erythema induratum of Bazin. Evidence of T-lymphocyte hyperresponsiveness to purified protein derivative of tuberculin: report of two cases and treatment. (1993) (30)
Antimicrobial Peptides and Skin: A Paradigm of Translational Medicine (2012) (30)
Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study (1991) (29)
Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers (1990) (29)
[The treatment of cutaneous radiation-induced fibrosis with pentoxifylline and vitamin E. An empirical report]. (1996) (29)
Efficacy of a Tyrothricin-Containing Wound Gel in an Abrasive Wound Model for Superficial Wounds (2012) (29)
The role ofCandida albicans secreted aspartic proteinase in the development of candidoses (1996) (29)
The use of systemic antimycotics in dermatotherapy. (2000) (29)
Ketoconazole concentrations in human skin blister fluid and plasma. (1984) (28)
Differential effect of medium potent nonhalogenated double-ester-type and conventional glucocorticoids on proliferation and chemotaxis of fibroblasts in vitro. (1994) (28)
Cellulite – das größte Hautproblem des Gesunden? Eine Annäherung (2006) (28)
Antifungal susceptibility testing with dermatophytes (1991) (28)
Prednicarbate Versus Conventional Topical Glucocorticoids: Pharmacodynamic Characterization In Vitro (1997) (27)
Skin ceramides : Structure and function (1991) (27)
Influence of serum protein binding on theIn Vitro activity of anti-fungal agents (1995) (27)
The impact of skin viability on drug metabolism and permeation -- BSA toxicity on primary keratinocytes. (2006) (27)
Topical liposome drugs to come: what the patent literature tells us. A review. (1991) (26)
Late Cutaneous Schistosomiasis Representing an Isolated Skin Manifestation of Schistosoma mansoni Infection (2000) (26)
Durchführung des Epikutantests mit Kontaktallergenen Performing patch testing with contact allergens Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) und der Deutschen Gesellschaft für Allergie und klinische Immunologie (DGAKI) (2008) (25)
Tolerance to different toilet paper preparations: toxicological and allergological aspects. (1995) (25)
Which plant for which skin disease? Part 2: Dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications (2010) (25)
Multiple keratoacanthomas, giant keratoacanthoma and keratoacanthoma centrifugum marginatum: development in a single patient and treatment with oral isotretinoin. (1996) (25)
Changes in skin pH and resident flora by washing with synthetic detergent preparations at pH 5.5 and 8.5 (1991) (24)
Safety and Efficacy of Fluticasone Propionate in the Topical Treatment of Skin Diseases (2004) (24)
[Cellulite--the greatest skin problem in healthy people? An approach]. (2006) (23)
Liposomes: a drug carrier system for topical treatment in dermatology. (1994) (22)
Effect of iron limitation on protein composition and ultrastructure of Haemophilus ducreyi. (1990) (22)
Liposomes for atopic dry skin: the rationale for a promising approach (1993) (22)
Comparative Efficacy and Tolerability of Econazole Liposomal Gel 1%, Branded Econazole Conventional Cream 1% and Generic Clotrimazole Cream 1% in Tinea Pedis (1997) (22)
Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration. (1990) (22)
Fungicidal Activity Plus Reservoir Effect Allow Short Treatment Courses with Terbinafine in Tinea pedis (2008) (22)
Tazarotene: Therapeutic Strategies in the Treatment of Psoriasis, Acne and Photoaging (2004) (21)
Neue Entwicklungen in der medizinischen Mykologie (2001) (21)
The Benefit/Risk Ratio: A Handbook for the Rational Use of Potentially Hazardous Drugs (1998) (21)
Dry skin improvement by an oleosome emulsion as a carrier for sphingolipid1 (2004) (21)
Molecular responses to changes in the environmental pH are conserved between the fungal pathogens Candida dubliniensis and Candida albicans. (2000) (20)
Current antimicrobial susceptibility of cutaneous bacteria to first line antibiotics. (1998) (20)
Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts (1995) (20)
Ciclopiroxolamine Cream for Treating Seborrheic Dermatitis: A Double-Blind Parallel Group Comparison (2002) (20)
The secreted aspartic proteinases as a new target in the therapy of candidiasis. (2002) (20)
Evidence for the phagocytosis of intact oligolamellar liposomes by human keratinocytes in vitro and consecutive intracellular disintegration. (1993) (20)
Aquarium Dermatitis: Cercarial Dermatitis in an Aquarist (1998) (20)
Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis. (1992) (20)
Nail Penetration of Sertaconazole with a Sertaconazole-Containing Nail Patch Formulation (2006) (19)
Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans. (2013) (19)
High-Frequency Ultrasound in the Evaluation of Pharmacological Effects on the Skin (2002) (19)
Inhibitors of aspartic proteases in human diseases: molecular modeling comes of age. (1999) (18)
In Vitro Susceptibility of Dermatophytes from Munich to Griseofulvin, Miconazole and Ketoconazole (1990) (18)
Unusual coexistence of systemic lupus erythematosus and primary biliary cirrhosis. (1994) (18)
Immunohistochemical investigations of genital ulcers caused by Haemophilus ducreyi (1997) (18)
0.25% Prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate cream (2004) (18)
Qualitative and Quantitative Assessment of the Benefit-Risk Ratio of Medium Potency Topical Corticosteroids In Vitro and In Vivo (2000) (18)
Comparable Efficacy and Safety of Various Topical Formulations of Terbinafine in Tinea Pedis Irrespective of the Treatment Regimen (2007) (18)
Treatment of atopic eczema with evening primrose oil: rationale and clinical results (1992) (18)
Topical glucocorticoids with increased benefit/risk ratio (1993) (17)
Safety and efficacy of sertaconazole nitrate cream 2% in the treatment of tinea pedis interdigitalis: a subgroup analysis. (2010) (17)
Comparative in vitro susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G. (1986) (17)
ACUTE CHOLANGITIS AFTER ALLOPURINOL TREATMENT (1978) (16)
Hydroxyethyl starch‐induced itch: Relevance of light microscopic analysis of semi‐thin sections and electron microscopy (2007) (16)
Human plasma and skin blister fluid levels of griseofulvin following a single oral dose (2004) (15)
Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index (2012) (15)
Qualitative and quantitative assessment of the benefit-risk ratio of medium potency topical corticosteroids in vitro and in vivo: characterisation of drugs with an increased benefit-risk ratio. (2000) (15)
Rate and Extent of Percutaneous Absorption of Sertaconazole Nitrate after Topical Administration (2005) (14)
The hyperkeratotic variant of porokeratosis Mibelli is a distinct entity: clinical and ultrastructural evidence. (1996) (14)
[Microbial flora and odor of the healthy human skin]. (1988) (14)
Topical glucocorticoids and thinning of normal skin as to be assessed by ultrasound. (1993) (14)
Lectin typing of Haemophilus ducreyi. (1988) (14)
Allergie acute contact dermatitis due to Arnica tincture self-medication. (1995) (14)
The sign of Leser-Trélat: a paraneoplastic cutaneous syndrome that facilitates early diagnosis of occult cancer. (2000) (14)
Dermatomycoses of the Glabrous Skin (2003) (14)
Soluble Interleukin-2 Receptors in Serum and Urine of Patients with Chancroid and Their Response to Therapy (1990) (14)
Onychodystrophy and its management (2003) (14)
Shift from persistent oral pseudomembranous to erythematous candidosis in a human immunodeficiency virus (HIV)‐infected patient upon combination treatment with an HIV protease inhibitor (1998) (14)
Peroxisome Proliferator-Activated Receptors and their Ligands (2012) (13)
The influence of the pH-value on the growth of Brevibacterium epidermidis in continuous culture. (1995) (13)
Bioavailability, Antipsoriatic Efficacy and Tolerability of a New Light Cream with Mometasone Furoate 0.1% (2012) (13)
Dubowitz syndrome: atopic dermatitis, low birth weight dwarfism and facial dysmorphism. (1990) (13)
Candidose der Haut (2006) (13)
Therapie eines parungualen HPV-73-positiven Morbus Bowen mit Imiquimod-Creme (2006) (12)
Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers (1987) (12)
Influence of topical erythromycin preparations for acne vulgaris on skin surface pH (1993) (12)
Onychomycosis (2007) (12)
Light and electron microscopic findings in human epidermis reconstructed in vitro upon topical application of liposomal tretinoin. (1997) (12)
Improving Topical Non-Melanoma Skin Cancer Treatment: In vitro Efficacy of a Novel Guanosine-Analog Phosphonate (2014) (12)
Ceftriaxone given repeatedly cures manifest syphilis in the rabbit. (1987) (12)
Nichtmedikamentöses Management der Rosazea (2011) (12)
Evidenz-basierte Kosmetika: Konzept und Anwendung bei den Zielstellungen Licht-geschädigte Altershaut und Xerosis (2009) (11)
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell‐mediated immunity (2007) (11)
Medical devices in dermatology: topical semi‐solid formulations for the treatment of skin diseases (2012) (11)
Commercial glucocorticoid formulations and skin dryness. Could it be caused by the vehicle? (1991) (11)
Characterisation of penicillinase producing gonococci isolated in Munich, 1981-6. (1988) (10)
The detergent scrub method for quantitative determination of Malassezia furfur on chest and back skin: comparative evaluation of three different media (1991) (10)
Hautreinigung mit Syndets (1990) (10)
Do cutaneous coryneform bacteria produce short-chain fatty acids in vitro? (1991) (10)
[Evidence-based cosmetics: concepts and applications in photoaging of the skin and xerosis]. (2009) (10)
Tinea der freien Haut (2010) (9)
Atypical presentation of co-existent Haemophilus ducreyi and Treponema pallidum infection in an HIV-positive male. (1992) (9)
Receptor-Selective Retinoids for Psoriasis (2006) (9)
Preputial abscesses caused by beta-lactamase-producing gonococci. (1985) (9)
Effects of growth factors on the proliferation of human keratinocytes and fibroblasts in vitro. (1998) (9)
Does cantharides blister fluid provide access to the peripheral compartment? (1982) (9)
Monophasic, cohesive-polydensified-matrix crosslinking-technology-based hyaluronic acid filler for the treatment of facial lipoatrophy in HIV-infected patients. (2010) (9)
Intraindividual variations of 8-methoxypsoralen plasma levels (1981) (9)
Activity of Different Desoximetasone Preparations Compared to Other Topical Corticosteroids in the Vasoconstriction Assay (2008) (9)
Innovative Agents for Actinic Keratosis and Nanocarriers Enhancing Skin Penetration (2010) (9)
Resistance of Liposomal Sunscreen Formulations against Plain Water as well as Salt Water Exposure and Perspiration (2010) (9)
Fluconazole‐resistant oral candidosis in a repeatedly treated female AIDS patient (1994) (9)
Investigation of the synthetic route to pepstatin analogues by SPPS using O‐protected and O‐unprotected statine as building blocks (2009) (9)
Nutzen und Risiko von Kosmetika (2000) (8)
Plasmid content and protein I serovar of non-pencillinase-producing gonococci isolated in Munich (1988) (8)
Propolis-induced allergic contact dermatitis mimicking pemphigus vulgaris. (1998) (8)
One-shot treatment of uncomplicated gonorrhoea with third-generation cephalosporins with differing serum half-life. Results of a controlled trial with ceftriaxone and cefotaxime. (1989) (8)
[New developments in medical mycology]. (2001) (8)
Transcriptional Activity of Potent Glucocorticoids: Relevance of Glucocorticoid Receptor Isoforms and Drug Metabolites (2003) (8)
[Metabolism of drugs in the skin]. (1989) (8)
In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans (2006) (7)
Human polymerase α inhibitors for skin tumors. Part 2. Modeling, synthesis and influence on normal and transformed keratinocytes of new thymidine and purine derivatives (2010) (7)
Dermatologische Leitlinienarbeit 2007 in der Perspektive (2007) (7)
Vergleich der Wirksamkeit verschiedener topischer Glukokortikoidcremes und ‐salben im Vasokonstriktionstest: Überlegenheit von Hydrocortisonbutyrat gegenüber Hydrocortison (2005) (7)
Candida sake: a relevant species in the context of HIV-associated oropharyngeal candidosis? (1997) (7)
[Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone]. (1987) (7)
Images in reproductive medicine. Ultrastructural defects in acquired immotile sperm flagellae. (2000) (7)
Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment? (2005) (7)
Tinea capitis (2002) (6)
Skin Blister Fluid Levels of Ketoconazole During Repetitive Administration in Healthy Man (1989) (6)
[A clinical trial of desired and unwanted effects of topically applied glucocorticosteroids in the human]. (1990) (6)
Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid. (1992) (6)
Bactericidal activity of cefotiam and ceftizoxime against Neisseria gonorrhoeae in an in vitro model simulating plasma and cantharidal blister fluid levels after the single intramuscular application of one gram. (1986) (6)
Lichen ruber linearis im Verlauf der Blaschko-Linien (1998) (6)
[Antiperspirants and deodorants--ingredients and evaluation]. (1989) (6)
Tinea barbae due to Trichophyton mentagrophytes related to persistent child infection (1998) (6)
Tinea of glabrous skin (2009) (6)
Erythema multiforme-like eruption in association with severe headache following pyritinol. (1993) (6)
Effective Single Dose Treatment of Uncomplicated Gonorrhoea (1994) (6)
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G. (1984) (6)
Efficacy of ceftizoxime in the treatment of incubating syphilis in rabbits. (1993) (6)
Determination of 8-methoxypsoralen levels in plasma and skin suction blister fluid by a new sensitive fluorodensitometric method (1981) (6)
Trichophyton-rubrum-Syndrom mit Tinea axillaris als Teilmanifestation (1999) (6)
[Antimicrobial effects of in vitro-simulated ketoconazole-cantharidin blister fluid levels on candida albicans]. (1986) (6)
Sexuell übertragbare Erkrankungen (1990) (6)
Dermatika und Kosmetika (1995) (5)
[Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone]. (2005) (5)
The susceptibility of Neisseria gonorrhoeae strains to different cephalosporins and penicillin G depends on the auxotype. (1986) (5)
[Candidiasis of the skin]. (2006) (5)
Gonoblennorrhoea adultorum (gonococcal conjunctivitis)--a "disappearing disease" which does not disappear. (1985) (5)
Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrhea. (1984) (5)
Stellenwert von Itraconazol in der Behandlung von Pilzinfektionen der Haut, Nägel und Schleimhäute (2009) (5)
Human plasma and skin blister fluid levels of griseofulvin after its repeated administration (2004) (5)
Antimikrobielle Effekte des in vitro simulierten Ketoconazol‐Kantharidinblasenflüssigkeitsspiegel‐Profils bei Candida albicans *, ** /Antimicrobial Effects of Ketoconazole Concentration Profiles in Cantharidin Blister Fluid, Simulated in Vitro, on Candida albicans (1986) (5)
Eczematous skin lesions in X-linked immunodeficiency with hyper-IgM. (1989) (5)
[Arthritis and erythema nodosum as typical manifestations of a yersinia enterocolitica infection]. (1978) (5)
[Facial foreign body granulomas after dermal injection of a polylactate-based implant for wrinkles]. (2003) (5)
Interaction of drug-carrier systems with targets--a study using atomic force microscopy. (2010) (5)
In vitro activity of eight antimicrobial agents against non-penicillinase-producing gonococci isolated in Munich. (1988) (5)
[Mode of action of ciclopiroxolamine on Candida albicans]. (2002) (5)
Hallmarks of atopic skin in vitro - Mimicked by the means of a skin disease model based on FLG knock down (2011) (4)
[The immotile cilia syndrome. A rare form of male infertility]. (1994) (4)
Ciclopiroxolamine Cream 1% in the Treatment of Seborrhoeic Dermatitis (2002) (4)
Syndets in the Treatment of Atopic Eczema (1991) (4)
Evidenzbasierte Kosmetika: Konzept und Anwendung bei den Zielstellungen Cellulite, Striae distensae und Acne vulgaris (2008) (4)
Cefodizime penetration into skin suction blister fluid following a single intravenous dose (2004) (4)
PREVALENCE OF GONOCOCCI LACKING THE 2·6 MEGADALTON CRYPTIC PLASMID (1987) (4)
Efficacy of a deodorant and its components: Triethylcitrate and perfume (1991) (4)
Erhaltungsbehandlung und Frühintervention – Das neue Paradigma beim Management des atopischen Ekzems (2005) (4)
Generalisierte Mycobacterium avium-intracellulare Infektion infolge immunsuppressiver Therapie einer paraneoplastischen Dermatomyositis (1997) (4)
Vergleichende Bewertung der Wirkung und klinischen Wirksamkeit von terbinafinhaltigen und bifonazolhaltigen Topika bei der Behandlung der Fußmykose (2004) (4)
[Contact urticaria with transition to protein contact dermatitis in a cook with atopic diathesis]. (1990) (4)
Pseudoaneurysm of the heart complicating myocardial infarction. (1978) (4)
[Sexually transmissible diseases]. (1987) (4)
Direct evidence for uptake of intact liposomes encapsulating silver sulfadiazine by cultured human keratinocytes based on combined transmission electron microscopy and X-ray microanalysis (1997) (4)
Absence of extracellular enzyme activity and cytotoxicity in cell-free culture filtrates of Haemophilus ducreyi. (1991) (4)
Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo. (1984) (4)
Gütegesicherte rationelle Diagnostik und Therapie in der Dermatologie (1998) (4)
[Grover's disease following hemodialysis in a patient with renal failure]. (2004) (4)
[Diagnostic methods for species-specific differentiation of various dermatophytes. Possibilities and limitations]. (2008) (4)
Evidenzbasierte Dermatika und Kosmetika (2005) (4)
Treatment of gonorrhoea with cefotiam: activity in vitro and clinical results of a 1-gram single-dose regimen. (1985) (4)
Coincidence of primary malignant melanoma of skin and eye. Report of a case without B-K mole syndrome but with a further malignancy. (1983) (4)
Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea. (1984) (4)
[Tinea capitis. Therapeutic options in the post-griseofulvin era]. (2002) (3)
Prolonged urticaria with 17-1A antibody (1998) (3)
In-vitro-Verfahren zur Bewertung der Hautverträglichkeit von Chemikalien―speziell Detergentien (1991) (3)
Treatment of oligozoospermia by testolactone (1987) (3)
Pustulöse Dermatitis nach Anwendung einer zu hoch konzentrierten magistralen Dithranolzubereitung bei seborrhoischem Ekzem (1998) (3)
[Determination of pathogens in blood in disseminated gonococcal infection. Case report and overview of the literature]. (1983) (3)
Acknowledgements to reviewers (2004) (3)
[Oral candidiasis]. (2008) (3)
[Morphologic variants of genital ulcer caused by Haemophilus ducreyi]. (1989) (3)
Das Säuremantelkonzept von Marchionini und die Beeinflussung der Resident-Flora der Haut durch Waschungen in Abhängigkeit vom pH-Wert (1990) (3)
Vergleichende Bewertung der Wirkung und klinischen Wirksamkeit von terbinafinhaltigen und bifonazolhaltigen Topika bei der Behandlung der Fussmykose [Comparative evaluation of the activity and clinical effectiveness of terbinafine and bifonazole preparations in the treatment of pedal mycosis] (2004) (3)
Disseminated cutaneous glomangiomas in an adolescent boy. (2012) (3)
Increase of the relative frequency of penicillinase-producing Neisseria gonorrhoeae strains to more than five per cent in Munich. (1990) (3)
0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effects. (1996) (3)
Antimykotische Therapie Invasiver Mykosen — Standort und Perspektiven (2002) (3)
Lack of immunoglobulin A1 protease production by Haemophilus ducreyi. (1992) (3)
Can the clinical efficacy of different antibiotic dosage regimens in gonorrhoea be predicted from the gonocidal effect of the corresponding plasma level profiles simulated in vitro? (1987) (3)
Terbinafin-Topika (2008) (3)
Antitumor effects of guanosine-analog phosphonates identified by molecular modelling. (2010) (3)
[Maintenance treatment and early intervention--the new paradigm in the management of atopic eczema]. (2005) (3)
[Metronidazole therapy of rosacea. The drug and its indications]. (1983) (3)
Topische Glucocorticoidtherapie: Bei Bronchialasthma und entzündlichen Dermatosen (2003) (3)
[Topical terbinafine. Reduction of duration of therapy for tinea pedis]. (2008) (3)
Phytotherapie bei Hautkrankheiten (2010) (3)
Antitranspirantien und Deodorantien: Wirkstoffe und Bewertung (1989) (3)
Evaluation of cefotetan in uncomplicated gonorrhea. (1986) (3)
Antimykotika von A bis Z. Anwendung und Pharmakologie auf einen Blick. 4., neu bearbeitete und erweiterte Auflage (2006) (3)
Zur Bedeutung des positiven Epikutantests auf Lanolin (1993) (3)
Single-dose treatment of athlete’s foot with terbinafine: report from a Dermatology Expert Panel (2007) (3)
Skin Cleansing with Synthetic Detergents (1992) (2)
Akute allergische Kontaktdermatitis auf Arnika-Tinktur (1994) (2)
[Use of Lactobacillus as a probiotic factor to treat urogenital and intestinal infections as well as to prevent and treat allergic diseases]. (2004) (2)
Subject Index Vol. 18, 2005 (2005) (2)
Interdisziplinäre Aspekte der Notalgia paraesthetica (2008) (2)
Influence of glucocorticoid substances and the vehicle on skin irritancy: determination by profilometry. (1993) (2)
Orale Therapie von Onychomykosen (1989) (2)
Prospective analysis of STD related genital ulcers from Hamburg. (1998) (2)
Kandidosen und Dermatophytosen bei HIV-Infektion (1988) (2)
Physikalische Therapieverfahren bei Akne (2010) (2)
Synergistische Effekte der Antimykotika Terbinafin und Itraconazol (1999) (2)
Lektin-typisierung als leistungsfähiges epidemiologisches markersystem für Neisseria gonorrhoeae-infektionen (1988) (2)
[Dermatological guideline efforts for 2007 in perspective]. (2007) (2)
[Fungi overall! Skin and mucosal mycoses and their treatment]. (2003) (2)
Beruflicher Hautschutz: Gemeinsame Leitlinie der Arbeitsgemeinschaft für (2003) (2)
[Disseminated tuberculosis cutis colliquativa caused by hematogenous dissemination of Mycobacterium tuberculosis]. (1990) (2)
Perorale Behandlung der Rosacea conglobata mit Isotretinoin : Therapiekontrolle mit der 20 MHz-Sonographie (1997) (2)
Skin cleansing with synthetic detergents : chemical, ecological, and clinical aspects (1992) (2)
Zur Bewertung des mikroskopischen Direktnachweises von Chlamydia trachomatis mit fluoreszenzmarkierten monoklonalen Antikörpern bei venerologischandrologischen Fragestellungen (1987) (2)
Hautlipide bei mit Seborrhoe- und Sebostase-assoziierten Hauterkrankungen (1993) (2)
Diagnosis and Treatment of Melanoma. European Consensus ⴀbased Interdisciplinary Guideline Developed by the Guideline Subcommittee of the (2012) (2)
Presence of two strains of Neisseria gonorrhoeae in both the cervix and pharynx of a patient with disseminated infection caused by a single strain. (1988) (2)
Lectin typing ofHaemophilus ducreyi (1988) (2)
[Investigations on the regulation of secreted aspartyl proteases in a model of oral candidiasis in vivo]. (1998) (2)
übersichtsartikel Molekulare Grundlagen der antimykotischen Therapie: Review Article: Molecular basis of antimycotic therapy (1999) (2)
Onychomycosis (2007) (1)
Methods in Molecular Biology 499: Candida albicans. Methods and Protocols (2010) (1)
In vitro susceptibility of recent isolates of Neisseria gonorrhoeae to cephalosporins of different generations and penicillin G: a comparative evaluation. (1984) (1)
The Suppressive Effect of Serum Samples from Patients with Chancroid on Human Mononuclear Cells Correlates with the Clinical Picture and is Interleukin-2-Dependent (1993) (1)
Übersichtsarbeiten (2009) (1)
Rosacea (2009) (1)
Fungi belong to the pathogens causing infectious disease. (2005) (1)
Cultural proof of Neisseria gonorrhoeae in synovial fluid in disseminated gonococcal infection. (1983) (1)
[Generalized Mycobacterium avium-intracellulare infection due to immunosuppressive therapy of paraneoplastic dermatomyositis]. (1997) (1)
Dimorphism in Human Pathogenic and Apathogenic Yeasts. Contributions to Microbiology (2001) (1)
Multiple mechanisms mediate adherence of Candida albicans to cultured human keratinocytes (1993) (1)
[Tinea in glabrous skin: total quality management]. (1998) (1)
[Lectin typing as an efficient epidemiological marker system for Neisseria gonorrhoeae infections]. (1988) (1)
Skin absorption testing via reconstructed human epidermis - Results of the German validation study (2006) (1)
Immotile cilia syndrome. A rare cause of male infertility (1994) (1)
[Pathomechanisms in Candida albicans infections]. (1988) (1)
Evaluation of Therapeutic Benefits and Toxicological Risks Using Structure-Activity Relational Expert Systems (1998) (1)
[In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration]. (1988) (1)
An Overview and Assessment of the Use of the Antifungal Agents Itraconazole, Terbinafine, and Fluconazole in Dermatology (1998) (1)
Experimental evidence for amide hydrolysis of indomethacin in rabbit skin. (1990) (1)
Influence of various concentrations of cefotiam and ceftizoxime on the phagocytosis of gonococci by polymorphonuclear granulocytes. (1989) (1)
Skin tissue fluid levels of cefotiam in healthy man following oral cefotiam hexetil (2007) (1)
Susceptibility of neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results (2004) (1)
Morphological changes in Neisseria gonorrhoeae induced by various subinhibitory concentrations of cefotiam. (1987) (1)
Haut‐ und Schleimhautmykosen und ihre Therapie: Pilze überall! (2003) (1)
Kühlwirkung von Topika : Kenntnisstand und Bestimmungsmöglichkeiten in vivo und in vitro (1998) (1)
Zur Bedeutung der Auxotypisierung von Neisseria gonorrhoeae für die Auswertung von Gonorrhoe-Therapiestudien (1985) (1)
Therapeutische oder prophylaktische Vakzination bei Pilzinfektionen (2008) (1)
Tinea pedis und Onychomykose (2008) (1)
Verleihung des Forschungsförderpreises 2001 der Deutschsprachigen Mykologischen Gesellschaft (2002) (1)
Irritative und allergologische Aspekte der Verwendung Altpapier-haltiger Hygienepapiere im Analbereich (1992) (1)
Das Immotile-Zilien-Syndrom (1994) (1)
Resistenzsteigerung vom Mehrschrittyp bei in vitro wiederholt subinhibitorischen Konzentrationen von Zweitgenerationschinolonen ausgesetzten Neisseria gonorrhoeae-Isolaten (2005) (1)
Antimikrobielle Peptide und die Haut: Ein Paradigma der translationalen Medizin (2013) (1)
Allgemeine Mykologie: Pilze (1991) (1)
Management der Acne vulgaris: Fokus auf Clindamycin und Zink (2008) (1)
Poly-L-Lactic Acid (2004) (1)
Unkomplizierte Gonorrhoe―rationale Therapie heute (1991) (1)
TINEA DER FREIEN HAUT : GUTEGESICHERTES MANAGEMENT (1998) (1)
Diagnostik und Therapie der Urethritis (1993) (1)
Kulturell gesicherter Lupus vulgaris. Klinik, Histologie, Mikrobiologie und Therapie (1988) (1)
Invitro activity ofeight antimicrobial agents against non-penicillinas e-producing (1988) (0)
Contents Vol. 25, 2012 (2012) (0)
[Urethritis in the male, diagnosis and therapy]. (1985) (0)
Retracted Chapter: Borderline lepromatöse Lepra (2001) (0)
Subject Index Vol. 19, 2006 (2006) (0)
[Fever with vesicular exanthema and pharyngitis in a 20-year-old patient (Mycoplasma pneumoniae associated Stevens-Johnson syndrome)]. (1988) (0)
Book review (2005) (0)
Retracted Chapter: Allergische Kontaktdermatitis auf ätherische Öle bei Aromatherapie (1995) (0)
Abstracts – AAPS Topical Drug Products Workshop, March 26–28, 1990, USA (1990) (0)
ILDS Newsletter No. 23 (2012) (0)
Contents, Vol. 191, 1995 (1995) (0)
Multiple-Dose Pharmacokinetics ofOfloxacin inSerum,Saliva, and SkinBlister Fluid ofHealthy Volunteers (1990) (0)
[Treatment of neurodermatitis with liposomes]. (1995) (0)
[Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones]. (1989) (0)
Book Review (2005) (0)
ABC of Medical Law (2010) (0)
Retracted Chapter: Atypische Mykobakteriose (2003) (0)
Bactericidal effect of cefodizime against beta-lactamase-producing Neisseria gonorrhoeae in vitro. A comparison of level profiles in serum and tissue after intramuscular and intravenous administration in man. (1989) (0)
Acknowledgment to Referees for Dermatology 1995 (1995) (0)
R. Aly, K. R. Beutner, H. Maibach (eds.)Cutaneous infection and therapy (1998) (0)
Skin Candidosis in AIDS Patients. Effects of Ketoconazole and Itraconazole. Focus on Tissue Levels (1990) (0)
["Targets, drugs and carriers--novel therapeutic approaches"]. (2004) (0)
In vitro susceptibility of Neisseria meningitidis to benzylpenicillin: a survey of 82 fresh isolates from bacterial carriers belonging to the German army. (1980) (0)
Acknowledgement to reviewers (1985) (0)
Cefodizime inSerumandSkinBlister Fluid after Single Intravenous andIntramuscular DosesinHealthy Volunteers (1987) (0)
Internalization of Staphylococcus aureus is followed by features of necrotic and apoptotic cell death in cultured human keratinocytes (1998) (0)
[Treatment of seborrhoeic eczema with ketoconazole in comparison with an active agent-free cream]. (1991) (0)
Distribution of auxotypes and correlation to antibiotic susceptibility of 169 recent clinical Neisseria gonorrhoeae isolates from Munich (2004) (0)
Retracted Chapter: Juvenile Xanthogranulome (2003) (0)
Differentiation of the skin atrophy potential of conventional and new topical glucocorticoids by ultrasound (1992) (0)
Experten-Beirat / Impressum (2013) (0)
Toxicity Profile of Liposomal Anthracydines (1998) (0)
[Importance of the auxotyping of Neisseria gonorrhoeae for evaluating gonorrhea therapy studies]. (1985) (0)
Contents Vol. 22, 2009 (2009) (0)
[Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment]. (2003) (0)
Magistralrezeptur im Spannungsfeld (1999) (0)
7th Dermadays, Witten, April 21–22, 2010 (2010) (0)
Retracted Chapter: Panarteriitis nodosa cutanea benigna unter dem Bilde einer Livedo racemosa (2007) (0)
Vergleichende Bewertung des Nachweises von Urethritis und Zervizitis ausgelöst durch Neisseria gonorrhoeae und Chlamydia trachomatis mittels DNA-Sonde und Kultur (1992) (0)
Mini Book Reviews (1986) (0)
Grundlagen und ihre Wirkungen: Indifferente Behandlung (1995) (0)
Wirksamkeit, Verträglichkeit und Patientennutzen der ultraschallgestützten Wundreinigung gegenüber chirurgischem Débridement (2013) (0)
Retracted Chapter: Langerhans-Zell-Histiozytose (Hand-Schüller-Christian-Krankheit) (1995) (0)
AIDS: Opportunistische Pilz-Infektionen der Haut und Schleimhäute (1990) (0)
Zerkariendermatitis aus einem Aquarium (1999) (0)
[Benzylpenicillin-induced leucopenia in subacute bacterial endocarditis (author's transl)]. (1979) (0)
Diagnosestellung mittels Dermatoskopie und 20 MHz-Sonographie : Malignes Melanom versus Basaliom (1996) (0)
Hormone und Hormonderivate (1995) (0)
Pigmentstörungen bei Kortikoidinjektionen (1997) (0)
[Pathogen-host relations in sexually transmitted diseases]. (1986) (0)
Dermatomykosen als Berufskrankheiten: Erreger, Infektions-quellen und betroffene Berufe (1990) (0)
[Phytotherapy for skin diseases]. (2010) (0)
Methodik von klinischen Studien bei Acne vulgaris (1990) (0)
Vergleichende Studie der systemischen Entzündungsreaktionen bei Psoriasis vulgaris und allergischer Kontaktdermatitis (2013) (0)
Konfokale Mikroskopie: Behandlung und zelluläre Immunantwort des Basalzellkarzinoms auf die photodynamische Therapie (2013) (0)
Retracted Chapter: Morbus Bowen: Therapie mit Imiquimod (2005) (0)
GLUCOCORTICOIDE BEI EKZEM UND PSORIASIS : IN-VITRO-MODELLE ZUR UNTERSUCHUNG ERWUNSCHTER UND UNERWUNSCHTER WIRKUNGEN (1996) (0)
Osteoporose unter Langzeitbehandlung mit Glukokortikoiden -Bisphosphonate zur Prävention und Therapie (2000) (0)
An in vitro cytotoxicity study of the interactive effect of 24 binary and ternary mixtures from the GHS classification groups (2005) (0)
Subject Index Vol. 191,1995 (1995) (0)
Darstellung der Dermatoheliosis mit der 20 MHz-Sonographie (1997) (0)
Medizinprodukte in der Dermatologie: Topische halbfeste Formulierungen zur Behandlung von Hauterkrankungen (2012) (0)
[Diagnosis and therapy of gonorrhea]. (1993) (0)
Lichen aureus zosteriformis : Verlaufskontrolle mit der 20 MHz-Sonographie (1997) (0)
Title Page / Inhalt / Vorwort / Geleitwort (1987) (0)
[Bone marrow depression with peripheral pancytopenia under the treatment with an ampicillin/oxacillin combination (author's transl)]. (1979) (0)
Contents Vol. 209, 2004 (2004) (0)
Haut- und Schleimhaut-kandidosen: Einsichten in die Pathogenese schaffen neue Optionen für die Therapie und Prophylaxe (2002) (0)
12th Annual Meeting of the Skin Pharmacology Society (Part 1 of 2) (1996) (0)
Guideline on Steroids in Pregnancy (2010) (0)
[Fatal drug-induced Lyell syndrome in combined benoxaprofen-aurothioglucose therapy]. (1982) (0)
Apothekenbasierte Befragung zu Fenistil Hydrocort (2007) (0)
Epithelial cells establish direct antifungal defense through toll-like receptor (TLR) 4-mediated signalling (2006) (0)
Retracted Chapter: Papillomatosis confluens et reticularis Gougerot-Carteaud (2001) (0)
Contents, Vol. 180, 1990 (1990) (0)
Ultrasound follow up of steroid treatment (1995) (0)
Das Konzept der Nutzen-Risiko-Bewertung von Kosmetika und Topika: Theoretische Grundlagen und praktische Anwendung (2000) (0)
Wirkstoffhaltige Zubereitungen zur örtlichen Anwendung und ihre Wirkungen: Differente Behandlung (1995) (0)
Zur Therapie genitaler Chlamydieninfektionen (1983) (0)
Marchionini’s Acid Mantle Concept and the Effect on the Skin Resident Flora of Washing with Skin Cleansing Agents of Different pH (1992) (0)
[Oral candidiasis]. (2004) (0)
MOLEKULARE GRUNDLAGEN DER ANTIMYKOTISCHEN THERAPIE (1999) (0)
Pyoderma gangraenosum auf Vasculitis allergica (1991) (0)
> Bei pH-Werten im Neutralbereich kommt es zu vermehrtem Wachstum der Aknebakterien (2010) (0)
Vitamine und ihre Derivate: Retinoide (1995) (0)
12th Annual Meeting of the Skin Pharmacology Society (Part 2 of 2) (1996) (0)
Striae Distensae: A Deeper Understanding of their Pathogenesis for a Rational Therapy and Prophylaxis (2009) (0)
Antineoplastische Chemotherapeutika (Zytostatika) und Immunmodulatoren (1995) (0)
Retracted Chapter: Analrandkarzinom (2007) (0)
Retracted Chapter: Angiolymphoide Hyperplasie mit Eosinophilie (2001) (0)
Hydroxyäthylstärke‐induzierter Juckreiz – Relevanz der lichtmikroskopischen Untersuchung von Semidünnschnitten und der Elektronenmikroskopie (2007) (0)
Photosensibilisatoren: 8-Methoxypsoralen (1995) (0)
Infektionen der Haut: Sexuell übertragbare Erkrankungen (2007) (0)
Spezielle Mykologie: Pilzerkrankungen (1991) (0)
Contents Vol. 19, 2006 (2006) (0)
[Cooling action of topicals--present results and testing methods in vivo and in vitro]. (1998) (0)
Xerosis und Kallusformation als Schlüssel für das diabetische Fußsyndrom: Problemstellung und Management aus dermatologischer Sicht (2006) (0)
Retracted Chapter: Entropium bei lupus erythematodes (2001) (0)
Oral Treatment of the Onychomycoses (1990) (0)
Gewebshormone/Zytokine und Antagonisten: Antihistaminika (1995) (0)
Bullöse Dermatose und Hautgangrän durch paravasale Überinfusion (1994) (0)
Bedeutung von sekretorischen Aspartatproteinasen in einem oralen Kandidosemodell und in vivo (2000) (0)
Abstracts (pages 6-10) (2004) (0)
[Review article. Molecular basis of antimycotic therapy]. (1999) (0)
Hochauflösende optische Kohärenztomographie zum In-vivo-Nachweis von Demodex-Milben (2013) (0)
Dry skin improvement by an oleosome emulsion as a carrier for sphingolipid 1 1 Disclosure not available at press time. (2004) (0)
Retracted Chapter: Pseudoerythroprosopalgie bei Pyozele der Stirnbeinhöhle (1995) (0)
Subject Index Vol. 209, 2004 (2004) (0)
Der Weg ist das Ziel: Dermatologisches Drug Targeting (2003) (0)
Retracted Chapter: Melkerknoten (2005) (0)
Subject Index Vol. 22, 2009 (2009) (0)
Book review (2005) (0)
Verringerte Rezidivrate von Condylomata acuminata durch photodynamische Therapie in Kombination mit CO2-Laser (2013) (0)
A process for the production of recombinant proteins in microorganisms (2003) (0)
Professor Dr. Hans C. Korting zum Geburtstag (2012) (0)
Cephalosporine und Quinolone (1987) (0)
Mykosen der Haut und Nagelorgane: Mikrobiologie, Klinik und Therapie von Dermatophytosen (2003) (0)
Therapie der Onychomykose: systemisch oder topisch? (2001) (0)
Erfolgreiche Therapie einer ausgedehnten Larva migrans mit dem Breitspektrum-Anthelminthikum Albendazol (1995) (0)
Acknowledgement to Referees for Dermatology 2004 (2004) (0)
H. Vanden Bossche: Mycoses in AIDS Patients. (2009) (0)
Routinemäßiges Hautkrebs-Screening in Deutschland: Bilanz nach 4 Jahren (2013) (0)
Systemische versus topische Dermatotherapie: Grundlagen des Einsatzes (1995) (0)
NUTZEN UND RISIKEN TOPISCHER GLUCOCORTICOIDE (1997) (0)
Gonococcal carriage in the throat--no common findings anyhow? Absence of Neisseria gonorrhoeae in the pharynges of 158 repeatedly swabbed young men. (1981) (0)
Anwendungen von Dermatika in der Schwangerschaft (2005) (0)
Paradigmenwechsel in der Generierung neuer Antimykotika - Inhibitoren der sezernierten Aspartatproteinasen (Sap) von Candida albicans als Ziel einer gezielten Arzneistoffsynthese - Ergebnisse im Fluoreszenz- und Adhärenzassay (2011) (0)
[Systematic reviews]. (2009) (0)
K. Zürcher and A. Krebs: Cutaneous Drug Reactions (2009) (0)
Striae distensae: Vom vertieften Verständnis der Pathogenese zu rationaler Therapie und Prophylaxe (2009) (0)
Grundlagen einer rationalen Therapie der Tinea unguium (1990) (0)
Mykologisches Labor (2006) (0)
In vitro-bakterizidieeffekte von ofloxacin bei S. aureus (1988) (0)
Summen-a-mode-Verfahren bei Messungen der Hautdicke mit 20 MHz Sonographie (1993) (0)
Publikation von Leitlinien im JDDG (2008) (0)
Papulopurpurisches „Gloves-and Socks“-Syndrom (2009) (0)
Bedeutung von Trägersystemen für die kutane Applikation von Sphingolipid-Präkursoren (2005) (0)
Book review (2005) (0)
Bilharciasis cutanea tarda (1999) (0)
[The etiopathogenesis of ulcus molle: current status of knowledge--approaches to future research]. (1989) (0)
Das Immotile-Zilien-Syndrom : Eine seltene Form männlicher Infertilität (1994) (0)
Bilaterale areolare und periareolare Pityriasis versicolor (2010) (0)
[Balkan nephropathy]. (1979) (0)
Book review (2005) (0)
Contents, Vol. 188, 1994 (1994) (0)
Ausschreibung Nachwuchsförderpreis 2007 (2007) (0)
Dermatika in der Schwangerschaft (2006) (0)
Contents, Vol. 167, 1983 (2004) (0)
Onychomykose (2007) (0)
Durch Gram-negative Bakterien bedingte Hauterscheinungen bei septischen Krankheiten (1988) (0)
Zur gegenwärtigen Empfindlichkeit von N. meningitidis gegen Penicillin G in vitro: Eine Untersuchung an 82 frischen Keimträgerstämmen von Bundeswehrangehörigen (1980) (0)
Charakterisierung der Interaktion zwischen Candida albicans und Wirtszellen (2008) (0)
Increased expression of extracellular proteolytic activity in Candida albicans isolates from the oral cavities of HIV-infected patients (1993) (0)
Corticosteroid-Pulstherapie bei Alopecia areata: 10-Jahres-Langzeitergebnisse (2013) (0)
[Triple bacterial infection of the cervix uteri in benign gonococcal sepsis]. (1982) (0)
[In vitro bactericidal effects of ofloxacin on S. aureus]. (1988) (0)
High concentrations of antibiotic obtained for a short time excel more long-standing lower levels in the therapy of gonorrhoea. Implications of an in vitro model. (1988) (0)
Use of a transport medium in the search forSalmonella carriers — is it worthwhile? (2005) (0)
[Transmission of a beta lactamase-forming gonococcal strain between 2 Germans in Hamburg]. (1983) (0)
Präputialabszeß durch β-Laktamase-bildende Gonokokken (1983) (0)
[On the present in vitro-susceptibility of N. meningitidis to benzyl-penicillin. A survey based on 82 fresh isolates from bacterial carriers belonging to the German Army (author's transl)]. (1980) (0)
Tagung der DPHG: „Targets, Drugs and Carriers — Novel Therapeutic Approaches”︁ (2004) (0)
Book Review (2005) (0)
Retracted Chapter: Ichthyosis congenita Typ III, NELI Typ A (2003) (0)
Retracted Chapter: Naevus sebaceus giganteus mit Progression (2001) (0)
Retracted Chapter: Angiosarkom unter dem Bild eines Pseudo-Kaposi-Sarkoms (2005) (0)
Editorial (2005) (0)
[The correlation between biotype and antifungal sensitivity of Candida albicans]. (1987) (0)
Validation study on percutaneous absorption via human skin models (2004) (0)
Contents Vol. 18, 2005 (2005) (0)
[Incidence and specificity of Salmonella bacteria in West German military personnel. Efficient Salmonella carrier diagnosis]. (1980) (0)
Retracted Chapter: Stiff skin syndrome bei Diabetes mellitus (2003) (0)
[Efficacy of ofloxacin against Neisseria gonorrhoeae]. (1988) (0)
Increasing the JIF of mycoses: a challenge with several facets (2007) (0)
Acknowledgement to the Reviewers (2010) (0)
[Endemic nephropathy (Balkan nephritis)]. (1978) (0)

This paper list is powered by the following services:

Other Resources About Hans Christian Korting

en.wikipedia.org

What Schools Are Affiliated With Hans Christian Korting?

Hans Christian Korting is affiliated with the following schools: